Clinical Trials · NCT05230615
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 458
- Start date
- Apr 2022
- Locations
- 2 sites, Italy
- Primary endpoint
- Change in HbA1c (Glycated haemoglobin)